Search
Now showing items 1-2 of 2
Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda.
(Elsevier Ireland, 2013)
Objective: To determine factors associated with an unknown HIV serostatus among pregnantwomen admitted in
labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital
were ...
VS411 Reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics
(PLoS One, 2012)
Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels ...